A study of Lanabecestat (LY3314814) in Early Alzheimer’s Disease Dementia

Trial Identifier: 16557
Sponsor: AstraZeneca
Collaborator:
Eli Lilly and Company
NCTID:: NCT02972658
Start Date: March 2017
Primary Completion Date: October 2018
Study Completion Date: October 2018
Condition: Neurological & Brain - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations